CDK
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 24064 | Cirtuvivint ( SM08502 ) | 2143917-62-6 | ≧98.0% |  |
| Cirtuvivint是一种CDC样激酶（CLK）和双特异性酪氨酸磷酸化调节激酶 | ||||
| 237071 | Flavopiridol ( 夫拉平度 ) | 146426-40-6 | ≧98.0% | .png) |
| Alvocidib is a synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is subst | ||||
| 236271 | TP1287 | 2044686-42-0 | ≧97.0% |  |
| Alvocidib Prodrug TP-1287 is an orally bioavailable, highly soluble phosphate prodrug | ||||
| 62502 | TG02 ( SB1317 ) | 937270-47-8 | ≧98.0% | _937270-47-8.png) |
| SB1317 (TG02) is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. SB1317 was so | ||||
| 52105 | SNS-032 ( BMS-387032 ) | 345627-80-7 | 98% |  |
| SNS-032 has firstly been described as a selective inhibitor ofCDK2withIC50of 48 nM an | ||||
| 51614 | AMG-925 | 1401033-86-0 | 98% |  |
| AMG-925 is a potent and orally bioavailable dual inhibitor of CDK4 and FLT3, includin | ||||
| 2073106 | Lerociclib HCl (G1T38 HCl) | 2097938-59-3 | ≧98.0% | _2097938-59-3.png) |
| Lerociclib HCl (G1T38 dihydrochloride)是一种分化型口服CDK4 / 6抑制剂，对 | ||||
| 185235 | Trilaciclib (G1T28) | 1374743-00-6 | >98% |  |
| Trilaciclib是一种小分子竞争性细胞周期蛋白依赖性激酶4和6（CDK4 / | ||||
| 204302 | Lerociclib | 1628256-23-4 (free base) | 98% | .png) |
| Lerociclib，也称为G1T38，是一种口服，有效和选择性的CDK4 / 6抑制剂 | ||||
| 204305 | ICEC0942 HCl | 1805789-54-1 (HCl) | 98% Min. | .gif) |
| ICEC0942, also known as PPDA-001 and CT7001, is a potent, orally active and selective | ||||
| 2073107 | Trilaciclib hydrochloride (G1T28 hydrochloride) | 1977495-97-8 | 98% Min. | .png) |
| Trilaciclib是一种小分子竞争性细胞周期蛋白依赖性激酶4和6（CDK4 / | ||||
| 24020 | KB-0742 dihydrochloride | 2416874-75-2 | ≧98.0% |  |
| KB-0742 是一种有效的、选择性的、口服生物可利用的 CDK9 小分子抑 | ||||